Hasil Pencarian

✨ 5 results found - Searched 21219 records in 3ms.
cover

Skripsi

Hubungan Rasio Neutrofil-Limfosit dengan Frailty pada Pasien Lansia dengan Penyakit Paru Obstruktif Kronis
2022 | BY Fathia Amalia Faizal - Ika Fitriana
  • The Association Between Neutrophil to Lymphocyte Ratio and Frailty in Elderly with Chronic Obstructive Pulmonary Disease.
  • Nomor Panggil S22026fk
cover

Tesis

Hubungan Antara Limfopenia dengan Mex SLEDAI serta Terapi Imunosupresan dan Limfosit Total pada Pasien Lupus Eritematosus Sistemik
2022 | BY Faradiesa Addiena - Lugyanti Sukrisman - Iris Rengganis - Muhadi
  • Association between lymphopenia and MEX SLEDAI as well as the immunosupresant therapy and total lymphocytes in systemic lupus erythematosus patients.
  • Nomor Panggil T22574fk
cover

Tesis

Korelasi Antara Skor Depresi Dengan Rasio Neutrofil-Limfosit, Kadar Anti-dsDNA Dan Skor Mex-SLEDAI Pada Pasien Lupus Eritematosus Sistemik
2022 | BY Anna Mira Lubis - Sukamto Koesnoe - Rudi Putranto - Muhamad Nadim
  • Correlation Between Depression Score With NeutrophilLymphocyte Ratio, Anti-dsDNA Level, And Mex-SLEDAI Score in Systemic Lupus Erythematosus Patients.
  • Nomor Panggil T22502fk
cover

Tesis

Hubungan rasio trombosit limfosit dan rasio neutrofil limfosit darah dengan respons klinis pada pasien kanker paru karsinoma bukan sel kecil stage lanjut yang mendapat kemoterapi
2022 | BY Eliasta Simpar Sitepu - Dianiati Kusumo Sutoyo - Andika Chandra Putra - Jamal Zaini
  • Relationship between serum platelets to lymphocytes ratio and serum neutrophils to lymphocytes ratio with clinical response in advanced stage non-small cell lung cancer patients receiving chemotherapy.
  • Nomor Panggil T22442fk
cover

Tesis

Intensitas stromal tumor infiltrating lymphocytes (sTIL) dan ekspresi programmed death ligand 1 (PD-L1) sebagai prediktor respons patologis kanker payudara terhadap terapi neoadjuvan di RSCM
2022 | BY Devi Felicia - Puspita Eka Wuyung - Primariadewi Rustamadji
  • Stromal tumor infiltrating lymphocytes (sTIL) intensity and programmed death ligand 1 (PD-L1) expression as pathological predictors of breast cancer response to neoadjuvant therapy in RSCM.
  • Nomor Panggil T22252fk